These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 21150228

  • 21. [FOLFOX].
    Mishima H, Ikenaga M, Tsujinaka T, Yasui M, Kashiwazaki M, Miyazaki M, Hirao M, Fujitani K, Nakamori S.
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):911-4. PubMed ID: 16835479
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
    Kallen KJ, Hofmann MA, Timm A, Gödderz W, Galle PR, Heike M.
    Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170
    [Abstract] [Full Text] [Related]

  • 24. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
    Fuse N, Doi T, Ohtsu A, Takeuchi S, Kojima T, Taku K, Tahara M, Muto M, Asaka M, Yoshida S.
    Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M.
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [Abstract] [Full Text] [Related]

  • 27. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M, Yasuda H, Koda K, Yamazaki M, Tezuka T, Takenoue T, Kosugi C, Higuchi R, Yamamoto S, Watayo Y, Yagawa Y, Suzuki M.
    Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML, Fang CH, Liang LS, Dai LH, Wang XK.
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.
    Maindrault-Goebel F, Tournigand C, André T, Carola E, Mabro M, Artru P, Louvet C, de Gramont A.
    Ann Oncol; 2004 Aug; 15(8):1210-4. PubMed ID: 15277260
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
    André T, Tournigand C, Mineur L, Fellague-Chebra R, Flesch M, Mabro M, Hebbar M, Postel Vinay S, Bidard FC, Louvet C, de Gramont A.
    Ann Oncol; 2007 Jan; 18(1):77-81. PubMed ID: 17030548
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathy.
    Kanai M, Yoshioka A, Tanaka S, Nagayama S, Matsumoto S, Nishimura T, Niimi M, Teramukai S, Takahashi R, Mori Y, Kitano T, Ishiguro H, Yanagihara K, Chiba T, Fukushima M, Matsuda F.
    Cancer Epidemiol; 2010 Apr; 34(2):189-93. PubMed ID: 20308030
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.
    Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM.
    Trials; 2015 Mar 24; 16():110. PubMed ID: 25872567
    [Abstract] [Full Text] [Related]

  • 40. Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.
    Cavanna L, Bertè R, Bidin L, Civardi G, Anselmi E, Lazzaro A, Moroni CF, Palladino MA, Rodinò C, Vallisa D.
    J Chemother; 2005 Jun 24; 17(3):334-8. PubMed ID: 16038529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.